Apollo Hospitals Group, India’s largest integrated healthcare provider today unveiled the ZAP-X Gyroscopic Radiosurgery Platform, a revolutionary advancement in brain tumor treatment, marking a significant milestone as the first in South Asia to introduce this ground-breaking technology. With ZAP-X, Apollo Hospitals continues its legacy of innovation and commitment to providing world-class healthcare solutions for patients in India and across the world. ZAP-X introduces a new era in brain tumor treatment, offering patients a non-invasive, pain-free alternative with sessions lasting just 30 minutes. This transformative technology redefines precision with minimal radiation exposure, enabling new standards in effectiveness and patient comfort. Unlike conventional methods, ZAP-X utilizes a self-shielded, gyroscopic linear accelerator design, to direct radiosurgical beams from thousands of potential angles, accurately focusing radiation on the intended tumor or target. This innovative method improves patient outcomes by enhancing the ability to avoid critical structures like the brain stem, eyes, and optic nerves, while also drastically minimizing exposure to healthy brain tissue to safeguard a patient’s cognitive function. ZAP-X’s proven clinical capabilities will enable neurologists and neurosurgeons in treating Primary & Metastatic Brain tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgias, Movement Disorders such as Parkinson’s disease, Epilepsy and other intracranial lesions such as meningiomas, acoustic neuromas and pituitary adenomas, with better accuracy and fewer side effects to patients. Dr Prathap C. Reddy, Founder and Chairman, Apollo Hospitals Group said at the launch: “For more than four decades, Apollo Hospitals has been at the forefront of healthcare, continuously challenging limits to provide exceptional care. Upholding this tradition, we have unveiled ZAP-X, an innovative technology designed for the treatment of brain tumors. This new approach allows for non-invasive, pain-free sessions lasting 30 minutes, with minimal exposure to radiation. ZAP-X also comes with advanced safety protocols, including instant error detection and reduced radiation leakage, that ensure the patient’s well-being and quality of life post treatment. Furthermore, as an outpatient procedure it allows for greater convenience and accessibility for patients. We commit to ensure that this technology is made available for every citizen of our country and for people across geographies, as this will be a boon for how brain tumors are approached and treated. With the rising tide of Non-Communicable Diseases (NCDs), ZAP-X will be a new addition in our fight against NCDs, of whom cancers, form a significant portion.” The ZAP-X technology comes with key advantages which include it being non-invasive, thereby not requiring a surgical intervention for certain brain tumors, is pain-free; and offers frameless, pinpoint accuracy and real-time image guidance for shorter treatment durations and enhanced patient safety. ZAP-X demonstrates high success, ensuring effective control and relief for various conditions with minimal side effects. It achieves over 95% control rate in 10 years with minimal facial or trigeminal side effects. ZAP-X shows an exceptional 99.4% control rate in 5 years for small, defined tumors.Prof. John R. Adler, Founder and CEO, Zap Surgical and Professor of Neurosurgery, Stanford School of Medicine said, “Stereotactic radiosurgery is among the most important medical advancements of the past century. Eligible patients no longer must experience debilitating surgical resections, or potentially lose cognitive capacity by undergoing whole-brain radiotherapy. Instead, with ZAP-X radiosurgery, patients can now be quickly treated in an outpatient setting and often return to normal activities the same day with no incisions, and no pain.” While traditional brain surgeries last 3-4 hours, ZAP-X completes treatment within a single session lasting no more than 30 minutes. ZAP-X allows for a day-care procedure, enabling patients to return home post-treatment, unlike traditional surgeries requiring 4-7 days or more of hospitalization, and without the necessity of anesthesia. The Apollo Institute of Neurosciences stands as a pioneering force in revolutionizing neurological care across India and the region. With state-of-the-art facilities, including emergency services, neuro-ICUs, and rehabilitation centers, Apollo has achieved a remarkable milestone of over 180,000 successful neurosurgeries. Leveraging cutting-edge AI technology, the Institute has redefined stroke protocols, enabling swifter, more accurate diagnosis and treatment. Backed by a formidable team of over 300 neurosurgeons and neurologists, Apollo treats more than 25,000 patients annually, performing nearly 6,000 brain and spinal surgeries. This exceptional volume solidifies Apollo’s expertise in managing even the rarest and most complex neurological cases, attracting patients from around the world seeking unparalleled care. The unveiling of the ZAP-X platform reaffirms Apollo’s commitment to spearheading innovations that transform lives.

Apollo Knowledge, a leader in global healthcare training and workforce development, has launched a one-year, full-time Advanced Certification in Genomics (ACG) program in collaboration with the Sri Ramachandra Institute of Higher Education and Research (SRIHER) in Chennai. The initiative marks a major milestone for Apollo’s Global Workforce Development (GWD) program, which is designed to build a strong pipeline of genomics-trained clinical scientists for international healthcare systems. Launched in August 2025, the ACG program currently hosts 37 postgraduate students (M.Sc./M.Tech.) from diverse life sciences backgrounds. Modelled on the NHS England curriculum, it offers comprehensive learning in genetic testing, cancer genomics, bioinformatics and genetic counselling, supported by advanced laboratory and clinical exposure. In addition to scientific training, learners receive English language coaching, soft-skills development, and interview preparation to support international mobility. The program was formally inaugurated on 18 November 2025 in the presence of senior leaders from SRIHER, Apollo Knowledge and experts associated with the NHS. During the event, Prof. Dame Sue Hill, Chief Scientific Officer for England and the Head of Profession for healthcare science workforce in the NHS and associated bodies, highlighted that the partnership showcases how countries can work together to build the skilled workforce needed to advance genomic medicine. Mr Sivaramakrishnan Venkateswaran, CEO of Apollo Knowledge, emphasised that the collaboration strengthens Apollo Knowledge’s mission under its Global Workforce Development (GWD) initiative — equipping healthcare professionals with advanced technical, language and soft skills to pursue international careers, in line with India’s ‘Heal by India’ vision. 

Apollo Hospitals has announced the opening of its new 250-bed quaternary care hospital in Swargate, Pune on November 24, 2025. This is a major step in expanding world-class healthcare access across western India. The facility is part of a phased development plan and will scale up to 400 beds to support the growing healthcare needs of the region.(From left to right) Dr Madhu Sasidhar, Dr Suneeta Reddy, Dr Preetha Reddy, Mr. Arunesh Punetha and Dr Manisha Karmarkar at a press conference to announce the unveiling of Apollo Pune.The hospital features next-generation medical infrastructure, including modular operating theatres, advanced robotic surgical systems such as the Da Vinci Xi and Mako, and comprehensive critical care units with over 100 critical care beds. The centre offers highly specialised services across cardiac sciences, oncology, organ transplants, orthopaedics, and mother-and-child care. Dedicated neonatal and paediatric ICUs with IoT-enabled monitoring and telemedicine integration ensure enhanced safety and clinical responsiveness for young patients. Commenting on the launch, Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group, said that Apollo’s mission is to transform healthcare for India and the world, guided by the “Heal in India – Heal by India” vision, and to bring clinical excellence with compassion and affordability to every home. Dr. Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise Ltd., noted that the Pune hospital is a strategic addition to Apollo’s national expansion, strengthening access to high-end quaternary care and integrated healthcare network for Maharashtra. Built on Apollo’s unified digital ecosystem, the Pune facility enables seamless patient navigation from primary consultations to super-specialty and critical care through structured referral pathways. The hospital reinforces Apollo’s commitment to delivering compassionate, evidence-based, and accessible care for the city’s rapidly growing urban population.  

Apollo Hospitals have entered a partnership with Coal India Limited to provide quality healthcare services to more than 2.5 lakh employees, 5 lakh pensioners, and their families across the country. This historic partnership aims at improving access to quality health services by providing comprehensive medical treatment, along with preventive health programs, through Apollo's 44 hospitals across the country.  A Memorandum of Understanding (MoU) to this effect was signed in Chennai in the presence of Dr. Prathap C. Reddy, Chairman, Apollo Hospitals and Dr. Vinay Ranjan, Director (HR), Coal India Limited. Senior officials from Coal India and Apollo Hospitals were also present on the occasion. The tie-up is in line with Coal India's belief in the welfare of its workforce, which powers nearly 70% of the country's energy requirements. For employees and retirees, medical treatment on tariff basis replaces the earlier payments on the CGHS rate, ensuring easier accessibility and better affordability. Cashless medical treatment is provided through an integrated referral and billing process between Apollo Hospitals and the medical departments of Coal India. Beyond treatment, the initiative emphasises preventive health screenings and community wellness programs designed to improve workforce productivity and protect the well-being of coal workers and their families. This partnership is a great example of industrial leadership combined with social responsibility, integrating Swachh Bharat with Viksit Bharat.

The Week-Hansa Research Survey 2025 once again spotlights India’s most trusted hospitals, offering patients and families a reliable guide to quality care across the country. The nationwide assessment covers 19 major cities (including NCR) and ranks both multi-speciality hospitals and top institutions across 10 key specialities.This year’s survey reinforces Apollo Hospitals’ leadership, with the group featuring prominently among the top-ranked institutions across several cities and specialities. The Group’s consistent presence in the upper tiers of the list reflects strong clinical outcomes, advanced infrastructure, and a sustained focus on patient-centric care. For patients and caregivers, these rankings affirm Apollo’s reputation as a first-choice destination for complex, multidisciplinary treatment needs.  The survey’s robustness lies in its extensive expert input and rigorous validation. More than 2,300 healthcare professionals, including general physicians and specialists, were consulted to nominate and rate hospitals, while responses from experts directly associated with a hospital were excluded to minimise bias. Findings were further validated using factual data and telephonic interviews with senior clinicians across cities and specialities.The key Apollo Hospitals rankings under several categories are as follows:  BEST HOSPITALS – ALL INDIA Best Multispecialty Hospitals (All India)  HospitalRankApollo Hospitals, Chennai4Apollo Health City, Hyderabad11Apollo Multispeciality Hospitals, Kolkata22 Best Multispecialty Hospitals (Private)HospitalRankApollo Hospitals, Chennai2Indraprastha Apollo Hospitals, Delhi4Apollo Health City, Hyderabad7Apollo Multispeciality Hospitals, Kolkata17 Best Multispecialty Hospitals (Private – Listed on the Stock Exchange)HospitalRankApollo Hospitals, Chennai1Indraprastha Apollo Hospitals, Delhi2Apollo Health City, Hyderabad3Apollo Multispeciality Hospitals, Kolkata6 Best Multispeciality Hospitals (Emerging Hospitals)HospitalRankApollo Hospitals, Mumbai1Apollomedics Superspeciality Hospitals, Lucknow3Apollo Spectra Hospitals, Ameerpet, Hyderabad7 Best Hospitals by ZoneNorth ZoneHospitalRankIndraprastha Apollo Hospitals, Delhi4 North Zone – PrivateHospitalRankIndraprastha Apollo Hospitals, Delhi2 East ZoneHospitalRankApollo Multispeciality Hospitals, Kolkata1Apollo Hospitals, Bhubaneswar4 East Zone – PrivateHospitalRankApollo Multispeciality Hospitals, Kolkata1Apollo Hospitals, Bhubaneswar2 South ZoneHospitalRankApollo Hospitals, Chennai2Apollo Health City, Hyderabad4 South Zone – PrivateHospitalRankApollo Hospitals, Chennai2Apollo Health City, Hyderabad3 Best Hospitals by CityHospitalRankApollo Hospitals, Chennai1Apollo Health City, Hyderabad1Apollo Multispeciality Hospitals, Kolkata1Indraprastha Apollo Hospitals, Delhi2Apollo Hospitals, BG Road, Bengaluru2Apollo Hospitals, Ahmedabad2Apollo Hospitals, Bhubaneswar2Apollo Hospitals, Indore3Apollo KH Hospitals, Vellore3Apollomedics Superspeciality Hospitals, Lucknow4Apollo Speciality Hospitals, Chennai8Apollo Hospitals, Navi Mumbai9Apollo Adlux Hospitals11Apollo Speciality Hospitals – OMR, Chennai14 Best Hospitals by City – PrivateHospitalRankApollo Hospitals, Chennai1Apollo Health City, Hyderabad1Indraprastha Apollo Hospitals, Delhi1Apollo Multispeciality Hospitals, Kolkata1Apollo Hospitals, Bhubaneswar1Apollomedics Superspeciality Hospitals, Lucknow1Apollo Hospitals, BG Road, Bengaluru2Apollo Hospitals, Ahmedabad2Apollo Hospitals, Indore3Apollo KH Hospitals, Vellore3Apollo Speciality Hospitals, Chennai7Apollo Hospitals, Navi Mumbai8Apollo Adlux Hospitals10Apollo Speciality Hospitals – OMR, Chennai13Apollo Health City, Hyderabad1Apollo Multispeciality Hospitals, Kolkata1Indraprastha Apollo Hospitals, Delhi 2 Best Hospitals by SpecialisationCardiologyHospitalRankApollo Hospitals, Chennai1Apollo Health City, Hyderabad12Apollo Hospitals, Ahmedabad19 Diabetes CareHospitalRankApollo Hospitals, Chennai8 PediatricsHospitalRankApollo Children’s Hospital, Chennai4Indraprastha Apollo Hospitals, Delhi12 Pediatrics – Standalone HospitalsHospitalRankApollo Children’s Hospital, Chennai1 GastroenterologyHospitalRankApollo Hospitals, Chennai7Indraprastha Apollo Hospitals, Delhi11Apollo Multispeciality Hospitals, Kolkata12 OrthopedicsHospitalRankApollo Hospitals, Chennai6Indraprastha Apollo Hospitals, Delhi12 NeurologyHospitalRankApollo Hospitals, Chennai6Indraprastha Apollo Hospitals, Delhi10 OncologyHospitalRankApollo Cancer Centre, Chennai4Apollo Proton Cancer Centre, Chennai19 PulmonologyHospitalRankApollo Hospitals, Chennai4Indraprastha Apollo Hospitals, Delhi5Apollo Hospitals, Bengaluru12 Best Hospitals by Specialisation – ZonalNorth ZoneSpecialisationHospitalRankPulmonologyIndraprastha Apollo Hospitals, Delhi3OrthopaedicsIndraprastha Apollo Hospitals, Delhi4PediatricsIndraprastha Apollo Hospitals, Delhi5NeurologyIndraprastha Apollo Hospitals, Delhi5GastroenterologyIndraprastha Apollo Hospitals, Delhi8 South ZoneSpecialisationHospitalRankCardiologyApollo Hospitals, Chennai1Pediatrics (Standalone)Apollo Children’s Hospital, Chennai1PediatricsApollo Children’s Hospital, Chennai2OncologyApollo Cancer Centre, Chennai2PulmonologyApollo Hospitals, Chennai2GastroenterologyApollo Hospitals, Chennai3OrthopedicsApollo Hospitals, Chennai4PulmonologyApollo Hospitals, Bengaluru4NeurologyApollo Hospitals, Chennai4Diabetes CareApollo Hospitals, Chennai5CardiologyApollo Health City, Hyderabad6OncologyApollo Proton Cancer Centre10 West ZoneSpecialisationHospitalRankCardiologyApollo Hospitals, Ahmedabad2

 Apollo AyurVAID Hospitals, a part of the Apollo Hospitals Group, launched its state-of-the-art 35-bed hospital at Greams Road, Chennai. This new facility marks an important milestone in integrating Ayurveda with modern science, emphasising evidence-based, personalised care for complex non-communicable diseases and rehabilitation. The facility offers treatment in various specialties that include orthopedics, neuro and neurodegenerative disorders, metabolic and women's health issues, pediatric developmental disorders, elder care, and sports medicine. It also provides Ayurvedic para-surgical treatments for conditions such as anorectal problems, chronic wounds, and respiratory issues. The hospital seeks to merge traditional practices with modern clinical systems to offer holistic health solutions. Apollo AyurVAID is launched by Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, in the presence of Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., and Mr. Rajiv Vasudevan, Founder and Managing Director of Apollo AyurVAID Hospitals. Dr. Reddy termed Ayurveda one of the biggest gifts that India had ever given to the world, underlining its potential when practiced with precision, evidence, and safety. He said he was confident that the new hospital would be an icon of research-led, Ayurvedic healthcare, leading towards recovery and lifelong wellness. Dr. Preetha Reddy spoke of the restoration of body-mind balance and promotion of lifetime wellness by the hospital. She spoke about the ever-growing network of Apollo, covering all the four southern states, Delhi, and upcoming western and eastern parts of India, with a commitment toward holistic, patient-centric healthcare. Mr. Rajiv Vasudevan emphasised that Apollo AyurVAID Hospitals is committed to offering personalised care for root-cause diagnosis and treatment of complex non-communicable diseases, post-acute rehabilitation, and whole-person health, with the aim of making high-quality, safe, outcome-driven Ayurveda care accessible to all seeking holistic healing. Further, Apollo AyurVAID will provide the line of ‘Tested Safe’ AyurVaid products, a range that undergoes stringent quality testing. Safety reports can be checked by consumers via QR codes; thus, quality and transparency go hand in hand.

In a landmark partnership, Apollo Hospitals and Navi Mumbai International Airport have come together in the endeavour to establish advanced 24/7 medical centres at Terminal 1 of the airport, strengthening health accessibility for passengers, staff, and the community around the airport. This collaboration, inked through a recent Memorandum of Understanding (MoU), guarantees round-the-clock preparedness for any medical eventualities with facilities equipped to handle emergencies and disaster management.  This will involve setting up six medical centres, each manned by three doctors, eight nurses, and two drivers, all of whom will be Advanced Cardiovascular Life Support (ACLS) trained to provide competent critical care. In addition to these facilities, the airport will have two completely equipped Intensive Care Unit (ICU) ambulances for immediate emergency services. There are also 65 Automated External Defibrillators (AEDs) placed throughout the terminals for quick responses to cardiac emergencies.  Apollo Hospitals Navi Mumbai, only a few kilometres from the airport, will further drive emergency and disaster preparedness at the facility, thereby enhancing the ecosystem of safety. This is a shared commitment to embedding quality healthcare into the travel experience, in line with Apollo's mission under the leadership of Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., to make advanced healthcare accessible and reliable.  The integration of Apollo Hospitals' expertise with Navi Mumbai Airport's infrastructure aims at the delivery of not only timely emergency care but also an assuring healthcare presence round the clock for travellers and airport personnel. 

CNBC-TV18 honoured Dr. Prathap C Reddy, Founder and Chairman of Apollo Hospitals, on 7 November 2025 for his pioneering and enduring contributions to Indian healthcare. Dr. Reddy is widely regarded as a visionary who transformed the nation’s private healthcare landscape when he established Apollo Hospitals in 1983. His mission — to make world-class medical care accessible and affordable for every Indian — sparked a paradigm shift that continues to shape the sector today.  Dr. Reddy’s work has been instrumental in reversing the brain drain of Indian doctors. His commitment to building a strong, ethical, and quality-driven medical ecosystem encouraged thousands of skilled Indian clinicians working abroad to return home and serve their own people. His advocacy for preventive healthcare helped make routine health checks, early diagnosis, and patient awareness a mainstream practice across the country, benefiting millions.  Under his leadership, Apollo Hospitals has grown into Asia’s largest integrated healthcare network, encompassing advanced multi-specialty hospitals, a nationwide pharmacy chain, primary care and diagnostics centres, and one of the region’s strongest telemedicine footprints. His efforts also positioned India as a global hub for medical tourism, bringing patients from over 140 countries and contributing significantly to the nation’s health economy.  During the COVID-19 pandemic, Dr. Reddy played a crucial leadership role in driving comprehensive national response initiatives — from large-scale testing and vaccination programmes to telehealth expansion and critical-care support — impacting millions of lives at a time when the country needed it most.  Over the decades, Dr. Reddy has been honoured with numerous awards, including the Padma Vibhushan and Padma Bhushan, for his unparalleled service to healthcare and his contributions to India’s growth story. His legacy continues to guide the sector toward a future defined by quality, innovation, equitable access, and a steadfast belief that good health is the foundation of a stronger India. 

Chennai, 22 October, 2025: Apollo Hospitals, Greams Lane, Chennai, has another remarkable milestone in advanced cardiac care with the successful implantation of Tamil Nadu’s first Leadless Dual Chamber AVEIR Pacemaker. The complex procedure was performed by Dr. Karthigesan A. M., Senior Consultant Cardiologist & Electrophysiologist, and his expert cardiac team. The recipient was an 80-year-old male patient with hypertension, diabetes, a prior history of angioplasty, and chronic kidney disease on dialysis. He presented with a slow heart rate and recurrent loss of consciousness caused by age-related complete heart block. Given his high risk of infection with conventional pacemakers, the team opted for the innovative leadless pacemaker system a safer and more advanced alternative for such patients. The AVEIR dual chamber pacemaker represents the next generation of cardiac pacing technology. Unlike conventional pacemakers that require leads and a surgical pocket, this leadless system is implanted directly into the heart chambers through a minimally invasive catheter-based technique. This approach eliminates the need for open surgery and reduces  This cutting-edge device offers several advantages over traditional systems. The femoral vein approach allows for faster recovery and leaves no visible scar, while the absence of leads and a surgical pocket minimizes complications such as bleeding and infection. Its compact design enhances patient comfort, cosmetic outcomes, and long-term safety, while the wireless communication between the right atrium and ventricle enables synchronized, physiologic pacing that closely mimics the heart’s natural rhythm. The AVEIR system also integrates miniaturization, remote monitoring, and precision pacing, ensuring superior clinical outcomes and an improved quality of life.  Dr. Karthigesan A. M., Senior Consultant Cardiologist & Electrophysiologist, Apollo Hospitals, Greams lane, Chennai said, “the introduction of the AVEIR dual chamber leadless pacemaker marks a transformative step in cardiac rhythm management and a major milestone for Indian cardiology and Apollo Hospitals, Greams Lane, Chennai. This groundbreaking technology offers the precision of physiologic pacing while eliminating the traditional risks associated with leads and surgical pockets. We call it an ‘extraordinary leap for healthcare’ because it is compact, intelligent, and designed with the patient’s comfort and experience in mind. This advancement enables us to deliver safer, more comfortable, and longer-lasting cardiac care, and it has the potential to revolutionize the way pacemaker systems are used in the future.” Dr Ilankumaran kaliamoorthy, CEO, Apollo Hospitals, Chennai Region quoted, “At Apollo Hospitals, we are committed to adopting cutting-edge technologies that redefine patient care standards. The successful introduction of the AVEIR leadless pacemaker reinforces our focus on clinical excellence, innovation, and superior outcomes for our patients. This milestone strengthens our mission to bring world-class cardiac care within everyone’s reach.” Apollo Hospitals continues to lead the nation in cardiac innovation and excellence, integrating the latest medical technologies to enhance precision, safety, and patient comfort. With each such advancement, Apollo reaffirms its position as a pioneer in healthcare innovation and a global leader in patient-centric care.

Apollo Cancer Centre (ACC), India’s leading cancer care network, is spearheading awareness on hereditary cancers during Hereditary Cancer Awareness Week, on October 8, 2025, at Apollo Cancer Centre, Chennai. The initiative aims to educate families about inherited cancer risks, encourage early genetic testing, and promote proactive screening, empowering individuals to take control of their health before symptoms appear.  Hereditary cancers result from gene mutations passed down through families and account for about 5–10% of all cancer cases globally. In India, breast and ovarian cancers are among the most common hereditary cancers, with up to 10% linked to BRCA1 and BRCA2 mutations. Lynch syndrome, another inherited condition, is responsible for 2–3% of colorectal cancers, underscoring the importance of awareness and early intervention. At Apollo Cancer Centre, Chennai, a recent case of familial clustering demonstrated the power of timely diagnosis and treatment. Four members of a family from Guwahati—the mother, her two daughters, and her son—were diagnosed with cancers linked to Lynch syndrome. All four received treatment at Apollo and are now doing well, underscoring the life-changing impact of genetic awareness and multidisciplinary care. Dr. Venkat P, Senior Consultant – Surgical Oncology, Apollo Cancer Centre, Chennai, stated, “Cancer is not always sporadic; it can be inherited across generations. Genetic counselling and proactive screening are crucial to detect risk early and improve survival outcomes.”Dr. Priya Kapoor, Consultant – Surgical Oncology, Apollo Cancer Centre, Chennai, highlighted, “Families with multiple cases of colorectal, ovarian, or endometrial cancers must take their medical history seriously. Genetic testing, structured surveillance, regular colonoscopies, timely polyp removal, and preventive surgeries can help stop cancers before they develop fully.” Even the patients from Guwahati said: “When cancer struck four of us in our family, it felt devastating. But Apollo’s doctors guided us with care and compassion. Today, we carry hope instead of fear.” Reinforcing this vision, Mr. Harshad Reddy, Director – Group Oncology & International, Apollo Hospitals Enterprise Ltd, said, “Families might not realize that cancer may run in their genes until several loved ones are affected. At Apollo Cancer Centre, we are committed to bridging this gap through awareness, education, and proactive genetic care—because early action can change the course of a family’s future.”   Apollo Cancer Centre continues to lead India’s fight against hereditary cancers by raising awareness, driving prevention efforts, and instilling hope.  

Apollo Hospitals inaugurated a dedicated Centre for Respiratory Care at its Teynampet campus in Chennai, addressing the growing burden of respiratory illnesses in India. Established under the Apollo Institute of Pulmonology, the centre integrates advanced diagnostics, specialized treatments, and preventive programs to enhance pulmonary health.  The centre offers five structured screening and clinic programs targeting respiratory conditions, including basic asthma screening, advanced asthma management, interstitial lung disease evaluation, a quit smoking initiative, and early-stage pulmonary hypertension management. Each program provides thorough evaluation, personalized care plans, and patient education to promote long-term respiratory wellness. Equipped with state-of-the-art pulmonary function testing, sleep study facilities, bronchoscopy suites, and rehabilitation services, the centre supports seamless diagnosis and treatment. An integrated care model facilitates collaboration among pulmonologists, respiratory therapists, and critical care specialists to deliver effective outcomes. This launch underscores Apollo Hospitals’ dedication to tackling respiratory challenges linked to pollution, smoking, and post-COVID complications. Beyond clinical services, the Institute of Pulmonology prioritizes research, training, and community outreach to boost lung health awareness and prevention. Mr. Karan Puri, CEO of Apollo Specialty Hospital Teynampet & Apollo Proton Cancer Centre, highlighted that the institute enhances Apollo’s mission of accessible, patient-centred care through early diagnosis and coordinated management of respiratory diseases. Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead for Pulmonology, Sleep Medicine, and Lung Transplantation, emphasized that the centre streamlines the patient journey with structured screenings, precise diagnoses, and education. With this new centre, Apollo Hospitals strengthens its position as a leader in specialized healthcare, providing Chennai and the surrounding region a comprehensive hub for respiratory wellness grounded in innovation, expertise, and compassion. 

Apollo Hospitals has signed a landmark agreement with Iraq’s Ministry of Interior to manage and operate the Internal Security Force Hospital in Baghdad, marking a significant milestone in international healthcare collaboration. This partnership aims to deliver advanced medical care to Iraq's internal security forces and their families, while enhancing the hospital's infrastructure and healthcare standards. Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, emphasized the significance of the collaboration, stating, "This partnership will bring Apollo’s expertise in hospital management, advanced clinical care, and patient safety protocols to ensure the delivery of world-class healthcare services at the facility." She highlighted that this initiative strengthens healthcare services for Iraq's internal security personnel. Mr. Ouday Khudhair Saeed, First Secretary of Iraq, expressed confidence in the partnership's positive impact: "We are confident that this partnership will greatly benefit our internal security forces by providing them and their families with the quality healthcare they deserve." Dr. Prathap C. Reddy, Founder-Chairman of Apollo Hospitals, underlined how this agreement aligns with the hospital group's vision: “Heal in India, Heal by India, Heal from India.” He noted that this agreement reinforces the mission to extend India’s finest healthcare expertise across borders, bringing hope and healing to Iraq’s security forces and their families.” The collaboration signifies India’s expanding footprint in global healthcare, with Apollo Hospitals bringing world-class medical expertise to support critical healthcare infrastructure in Iraq.